Immunogenicity and safety of simplified vaccination schedules for the CYD-TDV dengue vaccine in healthy individuals aged 9-50 years (CYD65): a randomised, controlled, phase 2, non-inferiority study.

Autor:	Coronel-MartÍnez, Diana Leticia1 (AUTHOR) dianaLeticia.coronel@sanofi.com, Park, Juliana2 (AUTHOR), López-Medina, Eduardo3 (AUTHOR), Capeding, María Rosario4 (AUTHOR), Cadena Bonfanti, Andrés Angelo5 (AUTHOR), Montalbán, María Cecilia6 (AUTHOR), Ramírez, Isabel7 (AUTHOR), Gonzales, María Liza Antoinette8 (AUTHOR), DiazGranados, Carlos A9,10 (AUTHOR), Zambrano, Betzana11 (AUTHOR), Dayan, Gustavo9 (AUTHOR), Savarino, Stephen9 (AUTHOR), Chen, Zhenghong12 (AUTHOR), Wang, Hao12 (AUTHOR), Sun, Sunny12 (AUTHOR), Bonaparte, Matthew9 (AUTHOR), Rojas, Andrey13 (AUTHOR), Ramírez, Jenny Carolina13 (AUTHOR), Verdan, Mae Ann14 (AUTHOR), Noriega, Fernando9 (AUTHOR)
Zdroj:	Lancet Infectious Diseases. Apr2021, Vol. 21 Issue 4, p517-528. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu